Sexual dysfunction and antipsychotic treatment
Abstract
Human sexual function is complex and affected in many different ways by schizophrenia and the antipsychotic drugs used in its treatment. The evaluation of the effects of antipsychotics on sexual function in patients with schizophrenia is also complex because the deleterious effects of conventional antipsychotics are superimposed on the effects of the disease itself. Although not extensively researched, sexual dysfunction seems to be frequent in patients with schizophrenia, especially in men. Sexual dysfunction appears, in significant part, to be a direct consequence of dopamine antagonism, combined with indirect effects due to increased serum prolactin concentration. Atypical antipsychotics have a number of potential advantages over standard agents with regard to their impact on sexual function. Clinical reports indicate that atypical antipsychotics are associated with a lower incidence of sexual adverse events than conventional antipsychotics and that there may also be important differences between them in this regard. For example, dose-related increases in prolactin concentrations occur with risperidone whereas olanzapine is associated with mild and transient increases in long-term treatment. Treatment with clozapine does not result in prolactin elevation and, like olanzapine, only transient increases occur with ziprasidone therapy, but the risk of agranulocytosis with clozapine restricts its use. Quetiapine has no more effect on serum prolactin than placebo across its full dose range. Together with its low frequency of reproductive or hormonal side effects and a low incidence of extrapyramidal symptoms, the tolerability profile of quetiapine may be particularly beneficial for many patients. Sexual dysfunction can be an important source of distress to patients and adversely affects compliance, and is one of the factors that must be taken into account when selecting treatment.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sexual dysfunction in schizophrenia is estimated to be more frequent compared to normal controls and to affect 30-80% of women and 45-80% of men.
“Although there are relatively few systematic investigations concerning sexual disorders in schizophrenia (514), sexual dysfunction in schizophrenia is, compared to normal controls, estimated to be more frequent (515-519) and to affect 30-80% of women and 45-80% of men (512,515, 520-523).”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [522]
Conventional antipsychotics cause less sexual dysfunction than risperidone but more than the other novel antipsychotics.
“Conventional AP cause less sexual dysfunction than risperidone but more than the other novel AP (520,522).”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [522]
Cites
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705 · see citing works
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.1 · Cited by 1,347 · see citing works
Risperidone in the treatment of schizophrenia
Marder, S. R., & Meibach, R. C. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,194 · see citing works
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140 · see citing works
Arvanitis, L. A., & Miller, B. G. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00190-x · Cited by 806 · see citing works
Trân, P. V., Hamilton, S. H., Kuntz, A. J., Potvin, J. H., Andersen, S. W., Beasley, C. M., & Tollefson, G. D. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199710000-00010 · Cited by 712 · see citing works
Peuskens, J. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.6.712 · Cited by 551 · see citing works
Prolactin Levels and Adverse Events in Patients Treated with Risperidone
Kleinberg, D. L., Davis, J. M., Coster, R. D., van Baelen, B., & Brecher, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00011 · Cited by 307 · see citing works
Keck, P. E., Buffenstein, A., Ferguson, J. M., Feighner, J. P., Jaffe, W., Harrigan, E. P., & Morrissey, M. R. (1998) · Psychopharmacology · doi:10.1007/s002130050755 · Cited by 265 · see citing works
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia
Peuskens, J., & Link, C. G. G. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb10162.x · Cited by 252 · see citing works
Fulton, B., & Goa, K. L. (1997) · Drugs · doi:10.2165/00003495-199753020-00007 · Cited by 251 · see citing works
Prolactin and antipsychotic medications: mechanism of action
Petty, R. G. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00158-3 · Cited by 231 · see citing works
Sexual Dysfunction and Plasma Prolactin Levels in Neuroleptic-treated Schizophrenic Outpatients
GHADIRIAN, A. M., Chouinard, G., & Annable, L. (1982) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198208000-00004 · Cited by 225 · see citing works
Sexual dysfunction in male schizophrenic patients.
Aizenberg, D., Zemishlany, Z., Dorfman-Etrog, P., & Weizman, A. (1995) · PubMed · Cited by 213 · see citing works
New atypical antipsychotic medications
Jibson, M. D., & Tandon, R. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00023-5 · Cited by 211 · see citing works
Breier, A. F., Malhotra, A. K., Su, T., Pinals, D. A., Elman, I., Adler, C. M., Lafargue, R. T., Clifton, A. D., & Pickar, D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.294 · Cited by 207 · see citing works
Atypical antipsychotic agents: A critical review
Worrel, J. A., Marken, P. A., Beckman, S. E., & Ruehter, V. (2000) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/57.3.238 · Cited by 194 · see citing works
Gitlin, M. J. (1994) · PubMed · Cited by 193 · see citing works
Thioridazine and sexual dysfunction
Kotin, J., Wilbert, D. E., Verburg, D., & Soldinger, S. M. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.1.82 · Cited by 185 · see citing works
Crawford, A. M., Beasley, C. M., & Tollefson, G. D. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00036-4 · Cited by 185 · see citing works
Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia
Rao, M. L., Gross, G., Strebel, B., Halaris, A., Huber, G., Bräunig, P., & Marler, M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91147-9 · Cited by 154 · see citing works
Sexual Disturbances During Clozapine and Haloperidol Treatment for Schizophrenia
Hummer, M., Kemmler, G., Kurz, M., Kurzthaler, I., OBERBAUER, H., & Fleischhacker, W. W. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.631 · Cited by 126 · see citing works
Subjective utility ratings of neuroleptics in treating schizophrenia
Finn, S. E., Bailey, J. M., Schultz, R. T., & Faber, R. A. (1990) · Psychological Medicine · doi:10.1017/s0033291700036539 · Cited by 120 · see citing works
Priapism Associated With Conventional and Atypical Antipsychotic Medications
Compton, M. T., & Miller, A. H. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0510 · Cited by 118 · see citing works
Evidence that serotonin affects female sexual functioning via peripheral mechanisms
Frohlich, P. F., & Meston, C. M. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00344-9 · Cited by 115 · see citing works
Development of transient obsessive-compulsive symptoms during treatment with clozapine
Ziegler, J., & Béhar, D. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.2.272a · Cited by 112 · see citing works
Kasper, S. F., Tauscher, J. T., Kufferle, B., Barnas, C., Pezawas, L., & Quiner, S. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014189 · Cited by 98 · see citing works
Antipsychotic drug therapy and sexual dysfunction in men
Mitchell, J. C., & Popkin, M. K. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.5.633 · Cited by 88 · see citing works
Ziprasidone: An atypical antipsychotic drug for the treatment of schizophrenia
Stimmel, G. L., Gutierrez, M. A., & Lee, V. W. Y. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85003-2 · Cited by 83 · see citing works
Psychoactive Drugs and Human Sexual Behavior: The Role of Serotonergic Activity
Meston, C. M., & Gorzalka, B. B. (1992) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1992.10471616 · Cited by 82 · see citing works
Management of psychotropic-induced hyperprolactinemia.
Marken, P. A., Haykal, R. F., & Fisher, J. N. (1992) · PubMed · Cited by 82 · see citing works
Sexual dysfunction: the unspoken side effect of antipsychotics
Peuskens, J., Sienaert, P., & De Hert, M. (1998) · European Psychiatry · doi:10.1016/s0924-9338(98)82005-1 · Cited by 80 · see citing works
Sexual dysfunction: The unspoken side effect of antipsychotics
Peuskens, J., Sienaert, P. A., & Hert, M. D. (1998) · European Psychiatry · doi:10.1016/s0924-9338(97)89490-4 · Cited by 72 · see citing works
Sexuality and Serious Mental Illness
Buckley, P. F. (2013) · Routledge eBooks · doi:10.4324/9780203783368 · Cited by 64 · see citing works
Risperidone-induced prolactin elevations in premenopausal women with schizophrenia
Dickson, R. A., Dalby, J. T., Williams, R., & Edwards, A. L. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.1102b · Cited by 54 · see citing works
Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636).
Hamner, M. B., Arvanitis, L. A., Miller, B. G., Link, C. G. G., & Hong, W. W. (1996) · PubMed · Cited by 51 · see citing works
Ziprasidone, a New Atypical Antipsychotic Drug
Carnahan, R. M., Lund, B. C., & Perry, P. J. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.7.717.34575 · Cited by 50 · see citing works
Prolonged erection associated with risperidone treatment
Tekell, J. L., Smith, E. A., & Silva, J. A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.1097a · Cited by 44 · see citing works
Rosen, S. I., & Hanno, P. M. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)36751-4 · Cited by 43 · see citing works
Dent, L. A., Brown, W. C., & Murney, J. D. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.7.538.33672 · Cited by 38 · see citing works
Priapism from quetiapine overdose: first report and proposal of mechanism
Pais, V. M., & Ayvazian, P. (2001) · Urology · doi:10.1016/s0090-4295(01)01208-0 · Cited by 37 · see citing works
Ernes, C. E., & Millson, R. C. (1994) · The Canadian Journal of Psychiatry · doi:10.1177/070674379403900523 · Cited by 36 · see citing works
Recurrent Priapism During Treatment With Clozapine and Olanzapine
Compton, M. T., Saldivia, A., & BERRY, S. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.659 · Cited by 33 · see citing works
Priapism in a Patient Taking Sertraline
Rand, E. H. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1007e · Cited by 31 · see citing works
Risperidone-induced absence of ejaculation
Raja, M. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199909000-00007 · Cited by 25 · see citing works
Risperidone-Associated Priapism
Nicolson, R., & McCurley, R. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704000-00022 · Cited by 24 · see citing works
Priapism Following Trazodone Overdose with Cocaine Use
Myrick, H., Markowitz, J. C., & Henderson, S. (1998) · Annals of Clinical Psychiatry · doi:10.3109/10401239809147747 · Cited by 22 · see citing works
Risperidone-Induced Ejaculatory and Urinary Dysfunction
Madhusoodanan, S., & Brenner, R. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1109f · Cited by 20 · see citing works
Priapism following trazodone overdose with cocaine use.
Myrick, H., Markowitz, J. S., & Henderson, S. (1998) · Annals of Clinical Psychiatry · doi:10.1023/a:1026119116904 · Cited by 14 · see citing works
Quetiapine and risperidone in outpatients with psychotic disorders: Results of the QUEST trial
Mullen, J., Reinstein, M. J., Bari, M., et al. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)80284-3 · Cited by 14 · see citing works
[Risperidone-induced priapism].
Maizel, S., Umansky, L., & Knobler, H. Y. (1996) · PubMed · Cited by 14 · see citing works
A survey of psychosexual arousability in male patients on depot neuroleptic medication
Wesby, R., Bullmore, E. T., Earle, J., et al. (1996) · European Psychiatry · doi:10.1016/0924-9338(96)84784-5 · Cited by 12 · see citing works
Hellewell, J. S. E., & Gorman, A. P. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)80337-5 · Cited by 10 · see citing works
Moinfar, N., Goad, S., Brink, D. D., et al. (1994) · Psychiatric Services · doi:10.1176/ps.45.10.1044 · Cited by 7 · see citing works
Priapismus unter Clozapintherapie
Hövermann, P., Nürnbach-Roß, B., & Albrecht, J. (1997) · Der Nervenarzt · doi:10.1007/s001150050099 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · see citing works
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844 · see citing works
Sexual dysfunction in schizophrenia: focus on recent evidence
Baggaley, M. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.924 · Cited by 191 · see citing works
The Impact of Mental Illness on Sexual Dysfunction
Zemishlany, Z., & Weizman, A. (2008) · Advances in Psychosomatic Medicine · doi:10.1159/000126626 · Cited by 188 · see citing works
Dossenbach, M., Dyachkova, Y., Pirildar, S., Anders, M., Khalil, A., Araszkiewicz, A., Shakhnovich, T., Akram, A., Pecenak, J., McBride, M., et al. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2005.12.005 · Cited by 121 · see citing works
Dossenbach, M., Hodge, A., Anders, M., Molnár, B., Peciukaitiene, D., Krupka-Matuszczyk, I., Tatu, M., Bondar, V., Pecenak, J., Gorjanc, T., et al. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704005012 · Cited by 106 · see citing works
Kelly, D. L., & Conley, R. R. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.010 · Cited by 88 · see citing works
Hanssens, L., L'Italien, G., Loze, J.-Y., Marcus, R. N., Pans, M., & Kerselaers, W. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-95 · Cited by 85 · see citing works
Konarzewska, B., Wołczyński, S., Szulc, A., Galińska, B., Popławska, R., & Waszkiewicz, N. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.015 · Cited by 70 · see citing works
Montejo, Á. L., Arango, C., Bernardo, M., Carrasco, J. L., Crespo-Facorro, B., Cruz, J. J., del Pino, J., García Escudero, M. A., García Rizo, C., González-Pinto, A., et al. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2015.11.003 · Cited by 55 · see citing works
Byerly, M. J., Nakonezny, P. A., Bettcher, B. M., Carmody, T., Fisher, R., & Rush, A. J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.04.005 · Cited by 55 · see citing works
Sexual dysfunction in schizophrenia
Malik, P. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328017f6c4 · Cited by 54 · see citing works
Haro, J. M., Novick, D., Belger, M., & Jones, P. B. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2005.12.001 · Cited by 49 · see citing works
- Authors
- Cutler, A. J.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Cutler, A.J.
- ORCID
- Cutler, A.J.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 28
- Pages
- 69-82
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2111083453
- Cited by
- 176
- References
- 55
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 6 · 2019: 1 · 2018: 3 · 2017: 9 · 2016: 9 · 2015: 9 · 2014: 4 · 2013: 9 · 2012: 14
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychoneuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- sexual dysfunction, schizophrenia, antipsychotic drugs, atypical antipsychotics, typical antipsychotics, dopamine antagonism, prolactin elevation, quetiapine, risperidone, olanzapine, clozapine, ziprasidone, adverse drug reactions, medication adherence
- MeSH terms
- Female, Humans, Male, Schizophrenia, Sexual Dysfunction, Physiological, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
